Embry Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Embry Holdings has a total shareholder equity of HK$2.0B and total debt of HK$267.5M, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are HK$2.7B and HK$651.8M respectively.
Key information
13.2%
Debt to equity ratio
HK$267.50m
Debt
| Interest coverage ratio | n/a |
| Cash | HK$227.84m |
| Equity | HK$2.03b |
| Total liabilities | HK$651.85m |
| Total assets | HK$2.68b |
Recent financial health updates
Health Check: How Prudently Does Embry Holdings (HKG:1388) Use Debt?
Dec 04
Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?
Sep 30Recent updates
Health Check: How Prudently Does Embry Holdings (HKG:1388) Use Debt?
Dec 04Benign Growth For Embry Holdings Limited (HKG:1388) Underpins Its Share Price
Oct 02Improved Revenues Required Before Embry Holdings Limited (HKG:1388) Shares Find Their Feet
Feb 06Does Embry Holdings (HKG:1388) Have A Healthy Balance Sheet?
Sep 30Capital Allocation Trends At Embry Holdings (HKG:1388) Aren't Ideal
Jul 20Looking For Steady Income For Your Dividend Portfolio? Is Embry Holdings Limited (HKG:1388) A Good Fit?
Mar 21Our Take On The Returns On Capital At Embry Holdings (HKG:1388)
Feb 21Would Shareholders Who Purchased Embry Holdings' (HKG:1388) Stock Five Years Be Happy With The Share price Today?
Dec 19Our Take On The Returns On Capital At Embry Holdings (HKG:1388)
Nov 23
Financial Position Analysis
Short Term Liabilities: 1388's short term assets (HK$811.1M) exceed its short term liabilities (HK$364.9M).
Long Term Liabilities: 1388's short term assets (HK$811.1M) exceed its long term liabilities (HK$286.9M).
Debt to Equity History and Analysis
Debt Level: 1388's net debt to equity ratio (2%) is considered satisfactory.
Reducing Debt: 1388's debt to equity ratio has reduced from 22.4% to 13.2% over the past 5 years.
Debt Coverage: 1388's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 1388's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 10:23 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Embry Holdings Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mandy Shek | CGS International |
| Shadow LAU | Maybank Research Pte. Ltd. |
| Larry Cho | Yuanta Research |